文献速递类风湿关节炎

canstatin对类风湿关节炎中成纤维细胞驱动的血管过度形成的影响

Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2025-06-20

在重症联合免疫缺陷(SCID)小鼠类风湿关节炎(RA)模型中,类风湿关节炎滑膜成纤维细胞(RASF)介导螺旋样血管(HLV)形成,canstatin可显著减少HLV数量;RASF重复刺激较单次刺激显著减弱血管过度形成,RNA测序揭示相关通路。

要点

  • SCID小鼠中RASF特异性HLV形成早期即出现并持续增至第30天,canstatin显著减少HLV数量。
  • 与骨关节炎滑膜相比,RA血管中ANGPT2显著上调。
  • RASF重复刺激较单次IL-1β刺激显著降低IL-6、IL-11和CXCL2,并显著减弱血管过度形成。

核心结论

  • RASF在体外和体内均影响血管形成,结果支持canstatin能够改变RASF病理性HLV形成的观点。
  • 在SCID小鼠模型中,该过程由ANGPT2以不依赖血管内皮生长因子A的方式在分子水平调控,对RA病理生理的核心方面有显著贡献。

研究设计与样本

  • 在SCID小鼠RA模型中对RASF介导的螺旋样血管(HLV)形成进行描述,并用canstatin(阻断内皮细胞中血管生成素(ANGPT)/Tie2通路的抗血管生成IV型胶原片段)进行调控。
  • 对植入物和人滑膜进行ANGPT2/CD31与CXCL2免疫荧光检测。
  • RASF接受单次或重复白细胞介素(IL)-1β刺激,并进行免疫分析、实时聚合酶链反应和RNA测序。
  • 使用人脐静脉内皮细胞与荧光标记的RASF进行二维管形成和三维球体实验,分别在有/无canstatin、IL-11和CXCL2条件下评估。

主要发现

  • SCID小鼠中RASF特异性HLV形成开始较早并持续增加至第30天,canstatin显著减少HLV数量。
  • 与骨关节炎滑膜相比,RA血管中ANGPT2显著上调。
  • RASF重复刺激较单次IL-1β刺激显著降低IL-6、IL-11和CXCL2。
  • RASF单次刺激时,CXCL2和IL-11显著降低并伴随二维管形成减少,而重复刺激显著减弱血管过度形成。
  • RNA测序揭示导致管形成改变的潜在通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Hypervascularisation is a dominant feature of the inflamed synovium in rheumatoid arthritis (RA). As RA synovial fibroblasts (RASFs) are key cells of synovial pathophysiology and are located adjacent to the aberrant endothelial cells (ECs), we hypothesised that this interaction might be responsible for the pathological hypervascularisation. METHODS: In the severe combined immunodeficiency (SCID) mouse model for RA, RASF-mediated helix-like vessel (HLV) formation was described and modulated by canstatin, an antiangiogenic collagen IV fragment that blocks the angiopoietin (ANGPT)/Tie2 pathway in EC. ANGPT2/CD31 and CXCL2 immunofluorescence on implants and human synovium was performed. RASF were stimulated with interleukin (IL)-1β once or repetitively and immunoassays, real-time polymerase chain reaction and RNA sequencing were performed. Two-dimensional (2D) tube formation and 3-dimensional spheroid-based assays using human umbilical vein ECs and fluorescent-stained RASF with/without canstatin, IL-11 and CXCL2 were evaluated. RESULTS: In SCID mice, RASF-specific HLV formation started early and increased until day 30. The number of HLV was significantly reduced by canstatin. Compared to osteoarthritis synovium, ANGPT2 was significantly upregulated in RA vessels. Repetitive RASF stimulation significantly decreased IL-6, IL-11 and CXCL-2 compared to RASF stimulated once with IL-1β. When RASF was stimulated once, CXCL2 and IL-11 were significantly reduced along with 2D tube formation, while repetitive stimulation significantly attenuated hypervascularisation. RNAseq revealed underlying pathways leading to altered tube formation. CONCLUSIONS: We showed that RASF affect vascularisation in vitro and in vivo. The results support the idea that canstatin is able to alter the RASF pathological HLV formation. In the SCID mouse model, this was regulated on a molecular level mediated by ANGPT2 in a vascular endothelial growth factor A-independent manner, contributing significantly to one of the central aspects of RA pathophysiology.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Heck C, Zimmermann-Geller B, Haun S, et al. Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritis. Ann Rheum Dis. 2025. PMID: 40541454. doi:10.1016/j.ard.2025.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。